Stefan, N. & Targher, G.* Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine. Nat. Rev. Gastroenterol. Hepatol. 22, 226–227 (2025)
Stefan, N. ; Lonardo, A.* & Targher, G.* Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases. Nat. Rev. Gastroenterol. Hepatol., DOI: 10.1038/s41575-023-00880-2 (2023)
Uhlig, H.H.* et al. Precision medicine in monogenic inflammatory bowel disease: Proposed mIBD REPORT standards. Nat. Rev. Gastroenterol. Hepatol. 20, 810-828 (2023)
Kramvis, A.* et al. A roadmap for serum biomarkers for hepatitis B virus: Current status and future outlook. Nat. Rev. Gastroenterol. Hepatol. 19, 727-745 (2022)
Protzer, U. Viral hepatitis: The bumpy road to animal models for HBV infection. Nat. Rev. Gastroenterol. Hepatol. 14, 327-328 (2017)
Protzer, U. Epigenetic control of HBV by HBx protein-releasing the break? Nat. Rev. Gastroenterol. Hepatol. 12, 558-559 (2015)
Herrmann, K.* et al. Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers. Nat. Rev. Gastroenterol. Hepatol. 6, 170-183 (2009)